# NHS vs Private Medical Cannabis in the UK

Source: https://medcannaindex.com/nhs-vs-private

NHS specialists are legally allowed to prescribe medical cannabis, but it rarely happens, so most patients pay a private clinic. The NHS funds it in three cases: Epidyolex for seizures in Dravet and Lennox-Gastaut syndromes, Sativex for spasticity in multiple sclerosis, and nabilone for sickness caused by chemotherapy.

The full guide is at https://medcannaindex.com/nhs-vs-private.

It rests on these sources, checked on 2026-10-06:
- Medical cannabis (and cannabis oils) (NHS): https://www.nhs.uk/conditions/medical-cannabis/
- Cannabis-based medicinal products (NG144) (NICE): https://www.nice.org.uk/guidance/ng144
- Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614) (NICE): https://www.nice.org.uk/guidance/ta614
- Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615) (NICE): https://www.nice.org.uk/guidance/ta615
- Circular 018/2018: rescheduling of cannabis-based products for medicinal use in humans (Home Office): https://www.gov.uk/government/publications/circular-0182018-rescheduling-of-cannabis-based-products-for-medicinal-use-in-humans

From MedCannaIndex. Fees and product details are as recorded there and should be confirmed with the clinic or pharmacy. This is not medical advice: which product is suitable, and how much, is for the prescribing specialist.